The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Become By 2030 Compared To 2026?
The messenger ribonucleic acid (mRNA) synthesis raw materials market has experienced steady growth in its size over recent years. This market is projected to expand from $3.03 billion in 2025 to $3.12 billion in 2026, achieving a compound annual growth rate (CAGR) of 3.0%. Historically, this expansion has been driven by several factors, including the increasing demand for vaccines, advancements in molecular biology, greater research and development investments in synthetic biology, the emergence of infectious disease outbreaks, and the creation of efficient transcription enzymes.
The messenger ribonucleic acid (mrna) synthesis raw materials market size anticipates consistent expansion over the upcoming years. This market is projected to reach $3.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.0%. This forecasted growth is attributable to factors such as the increasing development of mrna-based therapeutics, the implementation of automated mrna synthesis platforms, a rise in personalized medicine efforts, the emergence of biotechnology manufacturing hubs, and advancements in nucleotide modifications. Key trends expected during this period involve the optimization of synthetic mrna, the creation of high-purity raw materials, the establishment of scalable in-vitro transcription processes, the standardization of the supply chain for mrna production, and a focus on quality control and regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
Which Growth Drivers Are Expected To Support The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Forward?
The increasing occurrence of cancer and persistent health conditions is anticipated to drive expansion in the mRNA synthesis raw materials market moving ahead. Cancer is characterized as a condition where abnormal cells proliferate without control, invading adjacent tissues and potentially disseminating to various body parts through the bloodstream and lymphatic systems. Generally, chronic illnesses are defined as health issues lasting a year or more, requiring ongoing medical care, hindering daily activities, or a combination of these factors. These mRNA synthesis raw materials find application in pharmaceutical research, vaccine creation, and the production of RNA-based therapies, providing enhanced immunogenicity, superior efficiency, and quicker manufacturing, all suitable for addressing cancer and chronic disorders. For example, in January 2024, data released by the American Cancer Society, a US-based non-profit, indicated that the United States is forecast to experience 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, an increase from 1,958,310 cases and 609,820 deaths in 2023. Moreover, in September 2025, the British Heart Foundation, a UK-based charity, reported that over 7.6 million people in the UK, comprising more than 4 million men and over 3.6 million women, currently live with cardiovascular disease. Projections suggest that, influenced by an aging populace and better survival rates, the count of affected persons could increase by approximately 1 million by 2030 and around 2 million by 2040. Consequently, the escalating prevalence of cancer and chronic health issues is a key driver for mRNA synthesis raw materials.
What Key Segment Areas Are Included In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Assessment?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Which Trends Are Influencing The Expansion Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Companies prominent in the messenger ribonucleic acid (mRNA) synthesis raw materials market are prioritizing the establishment of strategic collaborations to improve their technological capacities, expand their portfolios of high-quality raw materials, and accelerate the development of next-generation mRNA therapeutics. These strategic collaborations represent formal partnerships among biotechnology firms, enzyme developers, and nucleic acid technology providers, specifically designed for co-developing advanced IVT enzymes, modified nucleotides, capping analogs, or other crucial inputs that enhance mRNA yield, purity, stability, and safety. As an illustration, in September 2024, TriLink Biotechnologies, a US-based biotechnology company, partnered with Alphazyme LLC, a US-based custom molecular biology enzyme company, to launch the CleanScribe RNA Polymerase. This innovative IVT enzyme reduces double-stranded RNA formation by up to 85% during mRNA synthesis, thereby facilitating the creation of safer and more potent mRNA therapeutics.
Which Organizations Are Involved In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Access The Complete Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report:
Which Region Is The Dominant Market In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model